Treatment of hypertriglyceridemia in patients receiving parenteral nutrition

Journal of Parenteral and Enteral Nutrition

Volumn 35, Issue 5, 2011, Pages 610-615

  Visschers, Ruben G J ^a   Olde Damink, Steven W M ^a,b   Gehlen, Jolanda M L G ^c   Winkens, Bjorn ^d   Soeters, Peter B ^a   Van Gemert, Wim G ^a  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^c Admiraal de Ruyter Ziekenhuis   (Netherlands)

^d MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

albumin; hypertriglyceridemia; parenteral nutrition; transaminases; triglycerides

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; ALKALINE PHOSPHATASE; ASPARTATE AMINOTRANSFERASE; BILIRUBIN; ELECTROLYTE; GAMMA GLUTAMYLTRANSFERASE; GLUCOSE; INTRALIPID; LONG CHAIN FATTY ACID COENZYME A LIGASE; OMEGA 6 FATTY ACID; TRACE ELEMENT; VITAMIN;

ADULT; ALBUMIN BLOOD LEVEL; ALKALINE PHOSPHATASE BLOOD LEVEL; ARTICLE; BILIRUBIN BLOOD LEVEL; CLINICAL ARTICLE; FEMALE; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTRIGLYCERIDEMIA; INFLAMMATION; LEUKOCYTE COUNT; MACRONUTRIENT; MALE; PARENTERAL NUTRITION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; TREATMENT WITHDRAWAL;

ALBUMINS; EMULSIONS; FAT EMULSIONS, INTRAVENOUS; FEMALE; HUMANS; HYPERTRIGLYCERIDEMIA; LINEAR MODELS; LIVER DISEASES; MALE; MIDDLE AGED; PARENTERAL NUTRITION; PHOSPHOLIPIDS; RETROSPECTIVE STUDIES; SOYBEAN OIL; TRIGLYCERIDES;

EID: 80052363011     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607110389616     Document Type: Article

References (31)

1. Visschers RG, Olde Damink SW, Winkens B, Soeters PB, van Gemert WG. Treatment strategies in 135 consecutive patients with enterocutaneous fistulas. World J Surg. 2008 ; 32: 445-453
2. Dudrick SJ, Wilmore DW, Vars HM, Rhoads JE. Long-term total parenteral nutrition with growth, development, and positive nitrogen balance. Surgery. 1968 ; 64: 134-142
3. Ukleja A, Romano MM. Complications of parenteral nutrition. Gastroenterol Clin North Am. 2007 ; 36: 23-46 (Pubitemid 46654718)
4. Beath SV, Davies P, Papadopoulou A, et al. Parenteral nutrition-related cholestasis in postsurgical neonates: multivariate analysis of risk factors. J Pediatr Surg. 1996 ; 31: 604-606 (Pubitemid 26115658)
5. Luman W, Shaffer JL. Prevalence, outcome and associated factors of deranged liver function tests in patients on home parenteral nutrition. Clin Nutr. 2002 ; 21: 337-343 (Pubitemid 34846890)
6. Grau T, Bonet A, Rubio M, et al. Liver dysfunction associated with artificial nutrition in critically ill patients. Crit Care. 2007 ; 11: R10
7. Llop J, Sabin P, Garau M, et al. The importance of clinical factors in parenteral nutrition-associated hypertriglyceridemia. Clin Nutr. 2003 ; 22: 577-583 (Pubitemid 37455726)
8. Koruk M, Savaş MC, Yilmaz O, et al. Serum lipids, lipoproteins and apolipoproteins levels in patients with nonalcoholic steatohepatitis. J Clin Gastroenterol. 2003 ; 37: 177-182 (Pubitemid 36875582)
9. Reinshagen K, Zahn K, Buch C, et al. The impact of longitudinal intestinal lengthening and tailoring on liver function in short bowel syndrome. Eur J Pediatr Surg. 2008 ; 18: 249-253
10. Visschers RG, Olde Damink SW, Schreurs M, Winkens B, Soeters PB, van Gemert WG. Development of hypertriglyceridemia in patients with enterocutaneous fistulas. Clin Nutr. 2009 ; 28: 313-317
11. Yang SQ, Lin HZ, Lane MD, Clemens M, Diehl AM. Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis. Proc Natl Acad Sci U S A. 1997 ; 94: 2557-2562 (Pubitemid 27136914)
12. Alwayn IP, Gura K, Nosé V, et al. Omega-3 fatty acid supplementation prevents hepatic steatosis in a murine model of nonalcoholic fatty liver disease. Pediatr Res. 2005 ; 57: 445-452 (Pubitemid 40293615)
13. Klein CJ, Stanek GS, Wiles CE. Overfeeding macronutrients to critically ill adults: metabolic complications. J Am Diet Assoc. 1998 ; 98: 795-806 (Pubitemid 28317485)
14. Levy MM, Fink MP, Marshall JC, et al. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med. 2003 ; 31: 1250-1256 (Pubitemid 36444440)
15. Venus B, Prager R, Patel CB, Sandoval E, Sloan P, Smith RA. Cardiopulmonary effects of Intralipid infusion in critically ill patients. Crit Care Med. 1988 ; 16: 587-590
16. Hexeberg S, Hessevik I, Hexeberg E. Intravenous lipid infusion results in myocardial lipid droplet accumulation combined with reduced myocardial performance in heparinized rabbits. Acta Physiol Scand. 1995 ; 153: 159-168
17. Nordenström J, Jarstrand C, Wiernik A. Decreased chemotactic and random migration of leukocytes during Intralipid infusion. Am J Clin Nutr. 1979 ; 32: 2416-2422 (Pubitemid 10177085)
18. Yuan G, Al-Shali KZ, Hegele RA. Hypertriglyceridemia: its etiology, effects and treatment. CMAJ. 2007 ; 176: 1113-1120 (Pubitemid 46649735)
19. Feingold KR, Staprans I, Memon RA, et al. Endotoxin rapidly induces changes in lipid metabolism that produce hypertriglyceridemia: low doses stimulate hepatic triglyceride production while high doses inhibit clearance. J Lipid Res. 1992 ; 33: 1765-1776 (Pubitemid 23006653)
20. Alvarez C, Ramos A. Lipids, lipoproteins, and apoproteins in serum during infection. Clin Chem. 1986 ; 32: 142-145 (Pubitemid 17033795)
21. Visschers RG, Olde Damink SW, van Bekkum M, Winkens B, Soeters PB, van Gemert WG. Health-related quality of life in patients treated for enterocutaneous fistula. Br J Surg. 2008 ; 95: 1280-1286
22. Waitzberg DL, Lotierzo PH, Logullo AF, Torrinhas RS, Pereira CC, Meier R. Parenteral lipid emulsions and phagocytic systems. Br J Nutr. 2002 ; 87 (suppl 1). S49 - S57 (Pubitemid 34134103)
23. Wanten GJ, Calder PC. Immune modulation by parenteral lipid emulsions. Am J Clin Nutr. 2007 ; 85: 1171-1184 (Pubitemid 46740457)
24. Heller AR, Rössel T, Gottschlich B, et al. Omega-3 fatty acids improve liver and pancreas function in postoperative cancer patients. Int J Cancer. 2004 ; 111: 611-616 (Pubitemid 39045330)
25. Lee SI, Valim C, Johnston P, et al. Impact of fish oil-based lipid emulsion on serum triglyceride, bilirubin, and albumin levels in children with parenteral nutrition-associated liver disease. Pediatr Res. 2009 ; 66: 698-703
26. Puder M, Valim C, Meisel JA, et al. Parenteral fish oil improves outcomes in patients with parenteral nutrition-associated liver injury. Ann Surg. 2009 ; 250: 395-402
27. Piper SN, Schade I, Beschmann RB, Maleck WH, Boldt J, Röhm KD. Hepatocellular integrity after parenteral nutrition: comparison of a fish-oil-containing lipid emulsion with an olive-soybean oil-based lipid emulsion. Eur J Anaesthesiol. 2009 ; 26: 1076-1082
28. Aarsland A, Chinkes D, Wolfe RR. Hepatic and whole-body fat synthesis in humans during carbohydrate overfeeding. Am J Clin Nutr. 1997 ; 65: 1774-1782 (Pubitemid 27240693)
29. Koga Y, Ikeda K, Inokuchi K. Effect of complete parenteral nutrition including fat emulsion on plasma lipid. Surgery. 1974 ; 76: 278-285
30. Beau P, Meyran E, Chassin J, Matuchansky C. Cyclic parenteral nutrition in hospitalized adult patients: a 9-year experience. Clin Nutr. 1994 ; 13: 22-28 (Pubitemid 24057176)
31. Senkal M, Geier B, Hannemann M, et al. Supplementation of omega-3 fatty acids in parenteral nutrition beneficially alters phospholipid fatty acid pattern. JPEN J Parenter Enteral Nutr. 2007 ; 31: 12-17 (Pubitemid 46036292)